Quanta Pharma Aromasin 12.5mg x 50 tablets

£37.00

Description
Reviews (0)

Quanta Pharma Aromasin 12.5mg x 50 Tablets

Quanta Pharma Aromasin 12.5mg x 50 tablets provides a specialized formulation of exemestane, a steroidal aromatase inhibitor designed for advanced endocrine research. Unlike reversible inhibitors, exemestane binds permanently to the aromatase enzyme, offering a unique mechanism for studying estrogen suppression and hormonal feedback loops. This product is essential for investigations into breast cancer models, hormone-dependent conditions, and post–cycle therapy (PCT) protocols in animal studies. Each bottle contains 50 tablets of 12.5mg, allowing for precise, low-dose titration required in sensitive hormonal experiments. Quanta Pharma ensures strict manufacturing standards, guaranteeing chemical purity and dosage accuracy for reliable data in controlled laboratory settings.

Key Features

Irreversible Inhibition: Exemestane permanently disables aromatase enzymes, requiring new enzyme synthesis for recovery
Steroidal Structure: Unlike non-steroidal inhibitors, it mimulates the natural substrate of aromatase
Precision Dosing: 12.5mg tablets enable granular control for delicate hormonal balance studies
Extended Supply: 50–tablet configuration supports long–term research protocols without interruption
High Purity Standard: Manufactured with ≥99.8% chemical purity, verified by independent HPLC testing
Oral Bioavailability: Effective oral administration with well-documented pharmacokinetics
Quality Assurance: Produced in ISO-certified facilities under strict laboratory guidelines

Mechanism of Action

Exemestane functions as a suicide inhibitor of the aromatase enzyme (CYP19A1). It structurally resembles the natural substrate androstenedione, allowing it to bind irreversibly to the enzyme’s active site. Once bound, the enzyme is permanently deactivated and cannot convert androgens into estrogens. This mechanism leads to a profound and sustained reduction in circulating estrogen levels. Unlike reversible inhibitors, which dissociate from the enzyme, exemestane’s effects persist until the body synthesizes new aromatase enzymes. This unique property makes it a critical tool for studying the consequences of complete estrogen ablation and the resilience of hormonal feedback systems.

Research Benefits

Complete Estrogen Suppression: Achieves near-total inhibition of estrogen synthesis in observed models
Permanent Enzyme Deactivation: Provides a stable, long-lasting effect unlike reversible inhibitors
Breast Cancer Models: Essential for studying hormone-dependent tumor growth and regression
Hormonal Feedback Studies: Ideal for investigating hypothalamic-pituitary-gonadal axis responses to low estrogen
Bone Health Research: Useful for examining the impact of estrogen deprivation on bone density
Cardiovascular Impact: Allows study of lipid profile changes associated with severe estrogen suppression

When to Use

This compound is designated for research requiring irreversible aromatase inhibition. Utilize Quanta Pharma Aromasin when studying breast cancer mechanisms, hormone-dependent diseases, or the effects of extreme estrogen suppression. Ideal for models investigating the recovery of the HPG axis after permanent enzyme inhibition. Suitable for comparative studies between steroidal and non-steroidal aromatase inhibitors. Not suitable for research requiring temporary or reversible estrogen modulation.

Dosage Guidelines for Research

Standard Research Dosage: 12.5-25mg per day, depending on the specific model and desired level of suppression
Cycle Duration: Typically used in protocols ranging from 4-8 weeks, followed by extended recovery periods
Administration: Oral ingestion with food to maximize absorption and reduce potential gastric irritation
Monitoring: Mandatory regular assessment of bone density, lipid profiles, and hormonal panels
Discontinuation: Effects persist post-discontinuation due to irreversible enzyme binding; recovery requires new enzyme synthesis
Safety Protocols: Strict veterinary supervision required due to risks of osteoporosis and cardiovascular issues

Product Specifications

Compound: Exemestane (Aromasin)
Manufacturer: Quanta Pharma
Strength: 12.5mg per tablet
Quantity: 50 tablets per bottle
Chemical Class: Steroidal aromatase inhibitor (Suicide Inhibitor)
Purity: ≥99.8% (HPLC certified)
Form: Oral tablet
Storage: Store below 25°C in a dry, dark environment
Shelf Life: 3 years from manufacture date
Usage: Laboratory research and animal studies only

Conclusion

Quanta Pharma Aromasin 12.5mg x 50 tablets is a definitive tool for researchers investigating the profound effects of irreversible aromatase inhibition. Its unique steroidal structure and permanent enzyme deactivation mechanism distinguish it from other inhibitors, offering critical insights into estrogen-dependent pathologies and hormonal regulation. The 12.5mg dosage form allows for precise control in sensitive experiments, while the 50-tablet supply ensures continuity in long-term studies. With Quanta Pharma’s commitment to purity, this product enables high-integrity research into cancer models, bone health, and endocrine dynamics. Strict ethical oversight and monitoring are essential due to the compound’s potent and lasting physiological effects.